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1. Introduction 
Three different reducible crosslinks have been 
shown to be present in the collagen fibres of skin, ten- 
don, and bone obtained from young tissues. All three 
are based on the reactions of lysine- and hydroxyly- 
sine-derived aldehydes and, after reduction with boro- 
hydride, result in the formation of hydroxylysinonor- 
leucine (I) [I] , dihydroxylysinonorleucine (II) [2,3] 
and histidinohydroxymerodesmosine (III) [4,5] . 
During our early studies into the nature of these 
bonds we showed that in their non-reduced form two 
of them, I and III, were extremely labile, being readi- 
ly cleaved by dilute acids, a-amino-fl-thiols and ther- 
mal denaturation [f&7] as might be expected from 
their aldimine bond structures. However, the cross- 
link present in the less soluble tissues such as bone 
and cartilage, designated syndesine [S] , and later 
shown to be dehydro-dihydroxylysinonorleucine [3] 
was found to be relatively stable to the above re- 
agents. In order to account for this unusual stability 
we suggested that migration of the double bond of 
this aldimine could occur to form an enaminol and 
thereby stabilize the crosslink [9, lo] . 
This paper presents evidence confirming the pro- 
posal of an enaminol-type structure for dehydro-dihy- 
droxylysinonorleucine. In addition, the apparent labil- 
ity of the non-reduced form of Fraction C or ‘post- 
histidine’ peak is shown to be inconsistent with the 
structure of the reduced compound, histidinohy- 
droxymerodesmosine [4] , suggesting that this pro- 
posed crosslink is an artefact of the borohydride re- 
duction procedure. 
North-Holland Publishing Company - Amsterdam 
2. Methods and results 
2.1. Degradative studies of di-OH-LNL 
De-calcified calf bone was reduced with NaB2H, 
and the deuterated di-OH-LNL isolated from an acid 
hydrolysate by using the methods previously de- 
scribed [8, lo] . To a solution of the crosslink in 0.1 
M citrate buffer (pH 5.5) was added an aqueous solu- 
tion of NaIO, to give a final concn. of 0.001 M. After 
5 min, the excess of periodate was destroyed by the 
addition of sodium arsenite, the pH then adjusted to 
8.5 and the solution reduced with KBH4 for 30 min. 
The products, predominantly proline but with small- 
er amounts of OH-norvaline, were isolated by using 
the Locarte analyser. 
Fig. 1 shows the mass spectral traces of the triflu- 
oroacetyl methyl ester derivatives of both authentic 
proline and the proline isolated from the degraded 
deutero-di-OH-LNL. In the latter, the molecular ion 
peaks at m/e 225 and 226 are due to the non-deute- 
rated and mono-deuterated derivatives respectively, 
and measurements of the relative intensities showed 
that 46% of the proline was present as the deuterated 
derivative. On applying the periodate and reduction 
degradation to the tritium-labelled crosslink, 86% of 
the radioactivity was recovered as [ 3H] proline and 
[3H] OH-norvaline. 
2.2. Effect of acid phosphate buffer on the formation 
of Fraction C 
In fig. 2 the elution profile of an acid hydrolysate 
of rat tail tendon reduced with KB3H, is compared 
with that of an alkaline hydrolysate of the same tissue 
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Fig. 1. The partial mass spectra of trifluoroacetyl methyl ester derivatives of (a) authentic proline and (b) proline isolated from 
degraded eutero-dihydroxylysinonorleucine. 
treated for 2 hr at room temp. with 0.5 M NaH,PO, 
(pH 4.3) before reduction. Whereas OH-LNL is stable 
to the acid buffer treatment, Fraction C is not present 
in the phosphate-treated sample, but is replaced by an 
approximately equivalent amount, in terms of 3H-la- 
bel, of material that elutes in the position of the re- 
duced aldol condensation product (fig. 2). Although 
this compound is unstable to acid hydrolysis, alkaline 
hydrolysates of tendon reduced without phosphate 
treatment showed only trace amounts of aldol. 
3. Discussion 
The isolation and characterisation of proline, half 
of which was deuterium labelled, from deuterated di- 
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hydroxylysinonorleucine after the periodate and re- 
duction degradation procedure, clearly indicates that 
reduction of the structure existing in vivo must have 
occurred at C-5. 
On reduction of the aldimine bond form of the 
crosslink, the isotope would be retained only at C-6 
and therefore migration of the double bond must have 
taken place to give the more stable enaminol struc- 
ture. Borohydride reduction of the keto form of this 
tautomer would yield dihydroxylysinonorleucine. 
These findings confirm our original proposal that 
the increased stability of the dihydroxy- compared to 
the monohydroxy-derivative of dehydro-lysinonor- 
leucine is indeed due to the rearrangement of the 
structure to form an enaminol. The absence of the ad- 
ditional hydroxyl group in the case of dehydro-hy- 
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Fig. 2. The 3H radioactivity elution profiles using pyridine-formate buffers of (a) an acid hydrolysate of reduced rat tail tendon 
and (b) an alkaline hydrolysate of the tendon treated with acid phosphate buffer before reduction. 
droxylysinonorleucine prevents rearrangement of the 
structure occurring and the crosslink consequently 
has the lability expected of an aliphatic aldimine bond. 
It is probable that the location of these crosslinks 
is identical and two of the possible sites, the quarter 
stagger and overlap regions contain a similar sequence 
in which the hydroxylysine may be glycosylated [ 1 l] I 
Preliminary studies indicate that the crosslink is some- 
times glycosylated but it is unlikely that the presence 
of hexose units will affect the stability of the cross- 
link. 
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Scheme 1. Labelled products expected after periodate degradation and reduction of tritium- or deuterium-labelled dihydroxyly- 
sinonorleucine. Isotope at C-5 would produce labelled proline and hydroxynorvaline whilst at C-6 would result in the formation 
of labelled methanol. 
The rearrangement of dihydroxylysinonorleucine 
presumably takes place soon after the biosynthesis of 
the crosslink and this stabilization is, therefore, inde- 
pendent of the subsequent changes with maturation 
that result in the formation of a non-reducible cross- 
link [lo]. 
Our earlier studies of the third reducible compo- 
nent, previously referred to as Fraction C or ‘post- 
histidine’ peak indicated that it was extremely labile. 
This is confirmed by the present finding that the com- 
ponent appears to be cleaved by mild acid treatment 
of the tissue before reduction to yield the aldol con 
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Scheme 2. Biosynthesis of dehydro-dihydroxylysinonorleucine and subsequent stabilization by the formation of an enaminol 
structure. 
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densation product. The identification of the reduced 
compound as histidino-hydroxymerodesmosine has re. 
cently been reported [4] . It was proposed that bio- 
synthesis of the non-reduced form of this presumed 
crosslinking component proceeds through the Michael 
addition of a histidine residue to the aldol condensa- 
tion product and Schiff base formation of the alde- 
hyde function with a hydroxylysine residue. The pre- 
cise mode of attachment of the histidine residue pro- 
posed by Tanzer et al. [4] was confirmed by 13C 
NMR studies of Fraction C [5]. 
The presence of the aldimine bond in the proposed 
non-reduced form existing in vivo would readily ac- 
count for the labile nature referred to above. How- 
ever, although cleavage of the aldimine bond under 
mild acid conditions is conceivable, rupture of the 
Michael addition product involving histidine would 
not be expected; based on the structure proposed, al- 
dolhistidine should have been obtained after acid treat- 
ment. A more detailed study of the effects of acid pH 
suggested that inhibition of the formation of this com- 
pound on reduction is due to protonation of the imid- 
azole ring [ 121 , thus indicating that the histidine resi- 
due cannot be involved in covalent aIdol linkage in the 
native fibre. We conclude, therefore, that histidinohy- 
droxymerodesmosine is an artefact produced during 
the reduction of the collagen fibres, the borohydride 
promoting a base-catalysed Michael reaction. The non- 
reduced form of this structure consequently does not 
exist as an intermolecular crosslink in vivo. 
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